相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Attenuation of MPTP neurotoxicity by rolipram, a specific inhibitor of phosphodiesterase IV
Lichuan Yang et al.
EXPERIMENTAL NEUROLOGY (2008)
Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease
Zena DeMarch et al.
NEUROBIOLOGY OF DISEASE (2008)
Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis
Anne L. Astier et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Peripheral phosphodiesterase 4 inhibition produced by 4-[2-(3,4-bis-difluoromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-phenyl]-ethyl]-3-methylpyridine-1-oxide (L-826,141) prevents experimental autoimmune encephalomyelitis
C. S. Moore et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis
B Bielekova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Relationship between inflammatory lesions and cerebral atrophy in multiple sclerosis
ND Richert et al.
NEUROLOGY (2006)
Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis
V Viglietta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β
B Bielekova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A pilot study of recombinant insulin-like growth factor-1 in seven multiple sclerosis patients
JA Frank et al.
MULTIPLE SCLEROSIS (2002)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Rolipram reduces excitotoxic neuronal damage
F Block et al.
NEUROREPORT (2001)
VLA-4/CD49d downregulated on primed T lymphocytes during interferon-β therapy in multiple sclerosis
PA Muraro et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
B Bielekova et al.
NATURE MEDICINE (2000)
Therapeutic potential of phosphodiesterase-4 and-3 inhibitors in Th1-mediated autoimmune diseases
B Bielekova et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
